Adamas Pharmaceuticals Inc Logo Image

Adamas Pharmaceuticals Inc

Adamas Pharmaceuticals Inc Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Adamas Pharmaceuticals Inc

Adamas Pharmaceuticals Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Adamas Pharmaceuticals Inc

51-200 Employees
Based in Emeryville, California

Adamas Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems in the United States. The company’s lead product candidate ADS-5102, which completed the Phase II/III clinical trial for the treatment of Parkinson's disease, known as levodopa induced dyskinesia.

NASDAQ (See More NASDAQ Companies)
Drugs - Generic (See More Drugs - Generic Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol